These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 2495680)

  • 1. Immunotherapy using interleukin-2 diphtheria toxin chimer prolongs murine allografts.
    Mackie JD; Pankewycz OG; Hassarjian R; Murphy JR; Kelley VE; Strom TB
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2718-9. PubMed ID: 2495680
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment with a diphtheria toxin-related interleukin 2 fusion protein prolongs cardiac allograft survival in mice.
    Barrett LV; Murphy JR; Strom TB; Kirkman RL
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1130-1. PubMed ID: 2650076
    [No Abstract]   [Full Text] [Related]  

  • 3. Analysis of cytokine transcripts in pancreatic islet cell allografts during rejection and tolerance induction.
    Nickerson P; Pacheco-Silva A; O'Connell PJ; Steurer W; Kelley VR; Strom TB
    Transplant Proc; 1993 Feb; 25(1 Pt 2):984-5. PubMed ID: 8442291
    [No Abstract]   [Full Text] [Related]  

  • 4. Interleukin-2-diphtheria toxin fusion protein prolongs murine islet cell engraftment.
    Pankewycz O; Mackie J; Hassarjian R; Murphy JR; Strom TB; Kelley VE
    Transplantation; 1989 Feb; 47(2):318-22. PubMed ID: 2493178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein engineering of diphtheria toxin. Development of receptor-specific cytotoxic agents for the treatment of human disease.
    Murphy JR; Lakkis FG; vanderSpek JC; Anderson P; Strom TB
    Targeted Diagn Ther; 1992; 7():365-82. PubMed ID: 1633299
    [No Abstract]   [Full Text] [Related]  

  • 6. In vivo studies with chimeric toxins. Interleukin-2 fusion toxins as immunosuppressive agents.
    Shapiro ME; Kirkman RL; Kelley VR; Bacha P; Nichols JC; Strom TB
    Targeted Diagn Ther; 1992; 7():383-93. PubMed ID: 1633300
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of recombinant interleukin-2 in therapy for hematologic malignancies.
    Dutcher JP; Wiernik PH
    Semin Oncol; 1993 Dec; 20(6 Suppl 9):33-40. PubMed ID: 8284690
    [No Abstract]   [Full Text] [Related]  

  • 8. Prolongation of murine thyroid allografts by interleukin 2 (DAB486)-toxin and RS-61443.
    Hullett DA; Landry AS; Eckoff DE; Nichols JC; Eugui EM; Allison AC; Sollinger HW
    Transpl Int; 1992; 5 Suppl 1():S487-9. PubMed ID: 14621855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant toxins for the treatment of cancer.
    Kreitman RJ
    Curr Opin Mol Ther; 2003 Feb; 5(1):44-51. PubMed ID: 12669470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 2 toxin: a step toward selective immunomodulation.
    Murphy JR; Kelley VE; Strom TB
    Am J Kidney Dis; 1988 Feb; 11(2):159-62. PubMed ID: 3124610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted therapy to the IL-2R using diphtheria toxin and caspase-3 fusion proteins modulates Treg and ameliorates inflammatory colitis.
    Yarkoni S; Sagiv Y; Kaminitz A; Farkas DL; Askenasy N
    Eur J Immunol; 2009 Oct; 39(10):2850-64. PubMed ID: 19735074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerance induction to multiple donor rat islet allografts by intrathymic inoculation of spleen cell membrane antigens.
    Qian T; Ricordi C; Schachner R; Inverardi L; Alejandro R
    Transplant Proc; 1995 Dec; 27(6):3390. PubMed ID: 8540012
    [No Abstract]   [Full Text] [Related]  

  • 13. Unmodified pancreatic islet allograft rejection results in the preferential expression of certain T cell activation transcripts.
    O'Connell PJ; Pacheco-Silva A; Nickerson PW; Muggia RA; Bastos M; Kelley VR; Strom TB
    J Immunol; 1993 Feb; 150(3):1093-104. PubMed ID: 8423334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indefinite acceptance of heart but not skin or islet allografts in rats by total lymphoid irradiation without intrathymic injection of donor cells.
    Papalois B; Wahoff D; Aasheim T; Griffin R; Nelson L; Field J; Sutherland DE
    Transplant Proc; 1995 Dec; 27(6):3190. PubMed ID: 8539905
    [No Abstract]   [Full Text] [Related]  

  • 15. IL-2 and IL-4 double knockout mice reject islet allografts: a role for novel T cell growth factors in allograft rejection.
    Li XC; Roy-Chaudhury P; Hancock WW; Manfro R; Zand MS; Li Y; Zheng XX; Nickerson PW; Steiger J; Malek TR; Strom TB
    J Immunol; 1998 Jul; 161(2):890-6. PubMed ID: 9670967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic islets induce CD4(+) [corrected] CD25(-)Foxp3(+) [corrected] T-cell regulated tolerance to HY-mismatched skin grafts.
    Yoon IH; Choi SE; Kim YH; Yang SH; Park JH; Park CS; Kim Y; Kim JS; Kim SJ; Simpson E; Park CG
    Transplantation; 2008 Nov; 86(10):1352-60. PubMed ID: 19034003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Request to clone a hybrid toxin gene in E. coli K-12.
    Recomb DNA Tech Bull; 1985 Dec; 8(4):191-3. PubMed ID: 3938033
    [No Abstract]   [Full Text] [Related]  

  • 19. Synergistic effects of combination therapy with human recombinant interleukin-2 and tumor necrosis factor in murine tumor models.
    Winkelhake JL; Stampfl S; Zimmerman RJ
    Cancer Res; 1987 Aug; 47(15):3948-53. PubMed ID: 3496953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy of murine sarcomas with interleukin 2. I. Local administration of human recombinant IL-2 preparations.
    Bubeník J; Indrová M; Toulcová A
    Folia Biol (Praha); 1986; 32(6):384-91. PubMed ID: 3492396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.